chr11-116846420-G-A

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP6_ModerateBS2

The NM_001366686.3(SIK3):​c.4086C>T​(p.Phe1362Phe) variant causes a synonymous change. The variant allele was found at a frequency of 0.00346 in 1,614,190 control chromosomes in the GnomAD database, including 13 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: 𝑓 0.0024 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0036 ( 12 hom. )

Consequence

SIK3
NM_001366686.3 synonymous

Scores

2

Clinical Significance

Likely benign criteria provided, single submitter B:2

Conservation

PhyloP100: 3.84

Publications

1 publications found
Variant links:
Genes affected
SIK3 (HGNC:29165): (SIK family kinase 3) Enables ATP binding activity; magnesium ion binding activity; and protein serine/threonine kinase activity. Involved in positive regulation of TORC1 signaling; positive regulation of TORC2 signaling; and protein phosphorylation. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
APOA1-AS (HGNC:40079): (APOA1 antisense RNA)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP6
Variant 11-116846420-G-A is Benign according to our data. Variant chr11-116846420-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 3024826.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Homozygotes in GnomAdExome4 at 12 AR,AD,Unknown gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SIK3NM_001366686.3 linkc.4086C>T p.Phe1362Phe synonymous_variant Exon 24 of 25 ENST00000445177.6 NP_001353615.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SIK3ENST00000445177.6 linkc.4086C>T p.Phe1362Phe synonymous_variant Exon 24 of 25 5 NM_001366686.3 ENSP00000391295.2 H0Y4E8

Frequencies

GnomAD3 genomes
AF:
0.00243
AC:
370
AN:
152216
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000603
Gnomad AMI
AF:
0.00768
Gnomad AMR
AF:
0.000392
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00248
Gnomad FIN
AF:
0.00565
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00382
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00306
AC:
770
AN:
251436
AF XY:
0.00331
show subpopulations
Gnomad AFR exome
AF:
0.000369
Gnomad AMR exome
AF:
0.000202
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00615
Gnomad NFE exome
AF:
0.00471
Gnomad OTH exome
AF:
0.00359
GnomAD4 exome
AF:
0.00357
AC:
5222
AN:
1461856
Hom.:
12
Cov.:
31
AF XY:
0.00361
AC XY:
2624
AN XY:
727224
show subpopulations
African (AFR)
AF:
0.000657
AC:
22
AN:
33480
American (AMR)
AF:
0.000335
AC:
15
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.0000765
AC:
2
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.00231
AC:
199
AN:
86256
European-Finnish (FIN)
AF:
0.00841
AC:
449
AN:
53420
Middle Eastern (MID)
AF:
0.000174
AC:
1
AN:
5744
European-Non Finnish (NFE)
AF:
0.00393
AC:
4370
AN:
1112004
Other (OTH)
AF:
0.00270
AC:
163
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
274
547
821
1094
1368
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
154
308
462
616
770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00243
AC:
370
AN:
152334
Hom.:
1
Cov.:
32
AF XY:
0.00242
AC XY:
180
AN XY:
74504
show subpopulations
African (AFR)
AF:
0.000602
AC:
25
AN:
41556
American (AMR)
AF:
0.000392
AC:
6
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5180
South Asian (SAS)
AF:
0.00248
AC:
12
AN:
4830
European-Finnish (FIN)
AF:
0.00565
AC:
60
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00382
AC:
260
AN:
68038
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
22
44
65
87
109
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00364
Hom.:
1
Bravo
AF:
0.00208
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00327
EpiControl
AF:
0.00308

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

SIK3-related disorder Benign:1
Apr 16, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
Jan 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

APOA1-AS: BS2; SIK3: BS2 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.31
CADD
Benign
11
DANN
Benign
0.83
PhyloP100
3.8
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.25
Details are displayed if max score is > 0.2
DS_DL_spliceai
0.25
Position offset: -37

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs150767868; hg19: chr11-116717136; COSMIC: COSV109417737; API